Vincerx Pharma, Inc. (VINC)
OTCMKTS · Delayed Price · Currency is USD
0.0125
0.00 (0.00%)
At close: Feb 5, 2026
Vincerx Pharma Employees
As of December 31, 2024, Vincerx Pharma had 13 total employees, including 12 full-time and 1 part-time employees. The number of employees decreased by 29 or -69.05% compared to the previous year.
Employees
13
Change (1Y)
-29
Growth (1Y)
-69.05%
Revenue / Employee
n/a
Profits / Employee
-$1,741,923
Market Cap
65.43K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 13 | -29 | -69.05% | 12 | 1 |
| Dec 31, 2023 | 42 | 1 | 2.44% | 42 | 0 |
| Dec 31, 2022 | 41 | -15 | -26.79% | 41 | 0 |
| Dec 31, 2021 | 56 | 28 | 100.00% | 56 | 0 |
| Dec 31, 2020 | 28 | - | - | 28 | 0 |
| Sep 30, 2020 | 2 | - | - | 2 | 0 |
| Jun 30, 2020 | 2 | - | - | 2 | 0 |
Vincerx Pharma News
- 7 months ago - Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal - GlobeNewsWire
- 7 months ago - Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders - GlobeNewsWire
- 8 months ago - Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal - GlobeNewsWire
- 10 months ago - Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewsWire
- 10 months ago - Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - GlobeNewsWire
- 11 months ago - Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI - GlobeNewsWire
- 1 year ago - Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives - GlobeNewsWire
- 1 year ago - Vincerx Pharma, Inc. Announces Reverse Stock Split - GlobeNewsWire